Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMAR International is a leading Contract Research Organization (CRO) providing comprehensive clinical research and regulatory services throughout the Middle East and North Africa (MENA) region. The company specializes in managing Phase I-IV clinical trials, offering expertise in site selection, monitoring, data management, and pharmacovigilance. By bridging the gap between global pharmaceutical companies and local healthcare infrastructures, AMAR International facilitates the development and registration of innovative therapies in emerging markets. Their therapeutic experience is broad, covering oncology, cardiology, infectious diseases, and endocrinology. The firm is particularly noted for its ability to operate in complex regulatory environments and its access to diverse patient populations across the Arab world. AMAR International also provides medical writing and quality assurance services to ensure compliance with international GXP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMAR International.